KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-cash Items: 2011-2025

Historic Non-cash Items for TherapeuticsMD (TXMD) over the last 13 years, with Sep 2025 value amounting to $949,000.

  • TherapeuticsMD's Non-cash Items rose 91.33% to $949,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 1164.38%. This contributed to the annual value of $3.5 million for FY2024, which is 1060.67% up from last year.
  • Per TherapeuticsMD's latest filing, its Non-cash Items stood at $949,000 for Q3 2025, which was up 678.66% from -$164,000 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Non-cash Items ranged from a high of $32.3 million in Q3 2022 and a low of -$18.2 million during Q4 2022.
  • Moreover, its 3-year median value for Non-cash Items was -$97,000 (2024), whereas its average is -$889,091.
  • As far as peak fluctuations go, TherapeuticsMD's Non-cash Items plummeted by 2,230.33% in 2023, and later skyrocketed by 355.93% in 2024.
  • TherapeuticsMD's Non-cash Items (Quarterly) stood at -$2.1 million in 2021, then slumped by 748.09% to -$18.2 million in 2022, then surged by 81.23% to -$3.4 million in 2023, then surged by 97.16% to -$97,000 in 2024, then soared by 91.33% to $949,000 in 2025.
  • Its last three reported values are $949,000 in Q3 2025, -$164,000 for Q2 2025, and $1.3 million during Q1 2025.